Price T Rowe Associates Inc. MD Sells 3,586 Shares of Cabot Co. (NYSE:CBT)

Price T Rowe Associates Inc. MD trimmed its holdings in shares of Cabot Co. (NYSE:CBT - Free Report) by 0.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 462,913 shares of the specialty chemicals company's stock after selling 3,586 shares during the period. Price T Rowe Associates Inc. MD owned 0.85% of Cabot worth $42,270,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. American Century Companies Inc. raised its position in shares of Cabot by 8.5% during the 4th quarter. American Century Companies Inc. now owns 1,323,347 shares of the specialty chemicals company's stock valued at $120,835,000 after acquiring an additional 103,380 shares during the last quarter. Sei Investments Co. grew its stake in shares of Cabot by 6.0% during the fourth quarter. Sei Investments Co. now owns 942,273 shares of the specialty chemicals company's stock worth $86,039,000 after purchasing an additional 53,090 shares during the period. Invesco Ltd. increased its holdings in Cabot by 7.1% in the fourth quarter. Invesco Ltd. now owns 845,261 shares of the specialty chemicals company's stock valued at $77,181,000 after purchasing an additional 55,905 shares during the last quarter. Copeland Capital Management LLC lifted its stake in Cabot by 21.6% in the fourth quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company's stock valued at $69,521,000 after buying an additional 135,119 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Cabot by 0.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 710,608 shares of the specialty chemicals company's stock worth $64,886,000 after buying an additional 3,175 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Stock Up 0.9 %

CBT traded up $0.67 during trading on Friday, reaching $77.89. The company had a trading volume of 506,147 shares, compared to its average volume of 395,599. The business's fifty day moving average price is $81.15 and its 200 day moving average price is $92.47. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. Cabot Co. has a 12 month low of $73.63 and a 12 month high of $117.46. The company has a market cap of $4.22 billion, a P/E ratio of 10.34, a PEG ratio of 0.74 and a beta of 1.04.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Equities analysts anticipate that Cabot Co. will post 7.57 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on CBT shares. UBS Group cut their price target on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research report on Monday, April 7th. JPMorgan Chase & Co. cut their target price on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a report on Friday, February 21st. Mizuho decreased their price target on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a report on Tuesday, January 7th. Finally, StockNews.com raised Cabot from a "hold" rating to a "buy" rating in a research note on Thursday, April 17th.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.